NeoGenomics Inc (NEO)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 4.58 | 4.25 | 4.27 | 4.08 | 4.29 | |
| DSO | days | 79.61 | 85.98 | 85.40 | 89.44 | 85.12 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 4.58
= 79.61
Neogenomics Inc.'s Days Sales Outstanding (DSO) has shown some fluctuations over the past five years. In 2023, the DSO decreased to 80.96 days from 85.72 days in 2022. This reduction suggests an improvement in the company's ability to collect its accounts receivable efficiently. However, it is important to note that the DSO was lower in 2019 and 2021 compared to 2023, indicating that there may have been some challenges in collections during 2020 and 2022. Overall, the trend in DSO for Neogenomics Inc. demonstrates a mix of performance in managing accounts receivable effectively over the years.